首页 › 非小细胞肺癌 › 加利福尼亚州 › Huntington Beach
Huntington Beach CA 非小细胞肺癌临床试验
14项针对 非小细胞肺癌的研究正在 Huntington Beach及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
招募中3 期
- City Of Hope - Seacliff /ID# 263143, Huntington Beach
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
招募中3 期
- Orange Coast Memorial Medical Center, Fountain Valley · 距离 4 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Memorial Care Orange Coast Medical Center Attn, Fountain Valley · 距离 4 英里
- MemorialCare Orange Coast Medical Center, Fountain Valley · 距离 4 英里
- OC Blood and Cancer Care, Fountain Valley · 距离 4 英里
- 以及另外 1 项
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- City of Hope Seacliff, Huntington Beach
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Fountain Valley · 距离 4 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- Local Institution - 007-777, Fountain Valley · 距离 4 英里
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
招募中3 期
- Orange Coast Memorial Medical Center Fountain Valley, Fountain Valley · 距离 4 英里
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
招募中1/2 期
- City of Hope, Huntington Beach
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
招募中2 期
- Compassionate Cancer Care Center, Fountain Valley · 距离 4 英里
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
招募中3 期
- MemorialCare - Orange Coast Medical Center, Fountain Valley · 距离 4 英里
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Research Site, Fountain Valley · 距离 4 英里
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
招募中2 期
- Los Angeles Cancer Network, Fountain Valley · 距离 4 英里
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
招募中2 期
- City of Hope Seacliff, Huntington Beach
GEMINI-NSCLC: NSCLC Biomarker Study
招募中观察性研究
- MemorialCare, Fountain Valley · 距离 4 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Huntington Beach的其他研究
- 特应性皮炎（湿疹）8 项研究
- 肥胖症7 项研究
- 心房颤动7 项研究
- 乳腺癌6 项研究
- 癌症（所有类型）6 项研究
- 超重5 项研究
- 脂肪性肝病5 项研究
- 结直肠癌5 项研究
- 心力衰竭5 项研究
- 2型糖尿病4 项研究
- 银屑病关节炎4 项研究
- 结肠癌4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。